Manitoba Pork Reports Only 3 Confirmed PED Cases In 2020

Jan 07, 2021

Manitoba Pork says there were minimal confirmed cases of the PED virus in 2020.

Jenelle Hamblin is Manager of Swine Health Programs.

"We did see only a total of three confirmed cases of PED in the province this past year. Two of which were in the spring, June was when they confirmed, late spring/early summer. The last one shortly there after in July, which was actually a known case from a direct animal movement from those previous two cases, which were both nurseries."

She talked about the drastic decrease from 2019.

"In 2019, it was officially our worst year on record for PED. We had 82 confirmed cases in the calendar year of 2019 and then down to only three in 2020. This time last year there was a lot of planing and discussion around different techniques, heightened bio-security practices to avoid a repeat of 2019. Some innovative thinking."

Hamblin says the COVID-19 lockdown and lack of movement among people may have also been a factor.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.